Aziende Socio Sanitarie Territoriale dei Sette Laghi

Running trials

• Active, not recruiting

  Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)

  NCT06430866· Phase 3· Amgen· Source

• Active, not recruiting

  Atezolizumab Versus Atezolizumab Plus Bevacizumab as First Line in NSCLC Patients (BEAT)

  NCT03896074· Phase 2· Fondazione Ricerca Traslazionale· Source

Closed trials

• Completed

  DOORS: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Change From Dipeptidyl Peptidase-4 Inhibitor (DPP4i) Treatment to Oral Semaglutide in Italy

  NCT05755360· Novo Nordisk A/S· Source

• Completed

  A Study to Explore Treatment Patterns, Treatment Outcomes, Healthcare Resource Utilization in Adult Participants With Myelofibrosis Through Chart Review

  NCT05444972· AbbVie· Source

• Completed

  Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis

  NCT04472598· Phase 3· AbbVie· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Chronic lymphocytic leukaemia10 works · 0 trials
• Myeloproliferative neoplasms9 works · 2 trials